• SPX
  • $5,917.11
  • 0 %
  • $0.13
  • DJI
  • $43,408.47
  • 0.32 %
  • $139.53
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,118.14
  • 0.41 %
  • $33.07
  • IXIC
  • $18,966.14
  • -0.11 %
  • -$21.33
Microbot Medical Inc. (MBOT) Stock Price, News & Analysis

Microbot Medical Inc. (MBOT) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.91

-$0.01

(-1.54%)

Day's range
$0.9
Day's range
$0.94
50-day range
$0.85
Day's range
$1.09
  • Country: US
  • ISIN: US59503A2042
52 wk range
$0.82
Day's range
$2.35


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -22.50
  • Piotroski Score 1.00
  • Grade Buy
  • Symbol (MBOT)
  • Company Microbot Medical Inc.
  • Price $0.91
  • Changes Percentage (-1.54%)
  • Change -$0.01
  • Day Low $0.90
  • Day High $0.94
  • Year High $2.35

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.86
  • Trailing P/E Ratio -1.26
  • Forward P/E Ratio -1.26
  • P/E Growth -1.26
  • Net Income $-10,740,000

Income Statement

Quarterly

Annual

Latest News of MBOT

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Microbot Medical Inc. Frequently Asked Questions

  • What is the Microbot Medical Inc. stock price today?

    Today's price of Microbot Medical Inc. is $0.91 — it has decreased by -1.54% in the past 24 hours. Watch Microbot Medical Inc. stock price performance more closely on the chart.

  • Does Microbot Medical Inc. release reports?

    Yes, you can track Microbot Medical Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Microbot Medical Inc. stock forecast?

    Watch the Microbot Medical Inc. chart and read a more detailed Microbot Medical Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Microbot Medical Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Microbot Medical Inc. stock ticker.

  • How to buy Microbot Medical Inc. stocks?

    Like other stocks, MBOT shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Microbot Medical Inc.'s EBITDA?

    Microbot Medical Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Microbot Medical Inc.’s financial statements.

  • What is the Microbot Medical Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Microbot Medical Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Microbot Medical Inc.'s financials relevant news, and technical analysis. Microbot Medical Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Microbot Medical Inc. stock currently indicates a “sell” signal. For more insights, review Microbot Medical Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.